These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21498996)

  • 1. Paclitaxel-resistant recurrent gastric cancer responsive to docetaxel: a case report.
    Kimura Y; Imasato M; Yano H; Taniguchi H; Danno K; Kanoh T; Ohnishi T; Tono T; Nakano Y; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):643-5. PubMed ID: 21498996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel].
    Nishikawa K; Iwase K; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Kawada J; Higashi S; Deguchi K; Noguchi Y; Okumura Y; Nomura M; Fushimi H; Takagi M; Fukui A; Fujitani K; Endo S; Tanaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2259-61. PubMed ID: 24394078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of docetaxel in patients with paclitaxel-resistant advanced gastric cancer.
    Kondoh C; Takahari D; Shitara K; Mizota A; Nomura M; Yokota T; Ura T; Ito S; Kawai H; Sawaki A; Muro K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1511-5. PubMed ID: 23064062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of advanced gastric cancer in which paclitaxel proved effective after resistance to docetaxel].
    Tsushima T; Tsuji Y; Abe S; Tanaka S; Tamura F; Mizushima T; Makino K; Oura K; Honda K; Sumiyoshi T; Yoshizaki N; Kondo H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1647-50. PubMed ID: 17940382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of effective weekly paclitaxel administration for advanced gastric cancer].
    Hasegawa Y; Kuroda F; Doi T; Takemura S; Nakamura H
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):655-7. PubMed ID: 21498999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent gastric cancer with peritoneal dissemination--prolonging life and good QOL by chemotherapy with combined use of paclitaxel].
    Hayashi Y; Akiyama J; Watanabe M; Nozaki Y; Iwashita R; Nagaoki Y; Sakurai T; Oshima T; Nagata N; Yago Y; Sako A; Kobayakawa M; Tamegai Y; Masaki N; Uemura N; Umeda N
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1861-4. PubMed ID: 18030025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced gastric cancer successfully treated with S-1 and paclitaxel followed by curative resection].
    Fukuda N; Sugiyama Y; Wada J; Niki M; Nomoto T
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1379-82. PubMed ID: 18701853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
    Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T
    Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy].
    Kimura Y; Taniguchi H; Fujita S; Kim C; Danno K; Kanoh T; Yoshida T; Ohnishi T; Tono T; Yamada Y; Kagawa K; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2324-6. PubMed ID: 23268065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy].
    Cho H; Kanari M; Sano H; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Imada T
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):129-32. PubMed ID: 12557718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
    Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy.
    Kimura Y; Yano H; Taniguchi H; Iwazawa T; Danno K; Kagara N; Kanoh T; Ohnishi T; Tono T; Nakano Y; Monden T; Imaoka S
    Jpn J Clin Oncol; 2011 Jun; 41(6):747-51. PubMed ID: 21498408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
    Lee JL; Ryu MH; Chang HM; Kim TW; Yook JH; Oh ST; Kim BS; Kim M; Chun YJ; Lee JS; Kang YK
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):631-7. PubMed ID: 17520252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer.
    Hironaka S; Zenda S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
    Gastric Cancer; 2006; 9(1):14-8. PubMed ID: 16557431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent gastric cancer with malignant ascites responding dramatically to chemotherapy with paclitaxel infused systemically and intraperitoneally].
    Morifuji M; Murakami Y; Yokoyama Y; Sasaki M; Hayashidani Y; Toge K; Sueda T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2027-30. PubMed ID: 15570933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
    Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
    Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel].
    Takashima T; Ito T; Sato T; Hirata K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1103-6. PubMed ID: 17637549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
    Cui Y; Li Q; Yu Y; Chen Y; Feng Y; Wang Y; Liu T
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):145-52. PubMed ID: 23064955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.